279 related articles for article (PubMed ID: 24873813)
1. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
Mele M; Mele A; La Torre PP; Cannone M
G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus.
Yildiz M; Karakoyun S; Acar RD; Ozkan M
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):95-6. PubMed ID: 23037320
[TBL] [Abstract][Full Text] [Related]
3. Massive pulmonary embolism in a young boy with T-cell leukaemia. Successful thrombolytic therapy by recombinant tissue plasminogen activator (rtPA).
Beck O; Martin C; Alt F; Wingerter A; Staatz G; Schinzel H; Faber J
Hamostaseologie; 2014; 34(3):233-6. PubMed ID: 24975773
[TBL] [Abstract][Full Text] [Related]
4. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
5. Successful thrombolytic therapy of post-operative massive pulmonary embolism after ultralong cardiopulmonary resuscitation: a case report and review of literature.
Yu Y; Zhai Z; Yang Y; Xie W; Wang C
Clin Respir J; 2017 May; 11(3):383-390. PubMed ID: 26083151
[TBL] [Abstract][Full Text] [Related]
6. [Fibrinolysis in pulmonary embolism].
Thabut G; Jebrak G
Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic and Anticoagulation Therapy in Patients Undergoing Ultrasound-Assisted Catheter-Directed Thrombolysis for Pulmonary Embolism.
Terry KJ; Buckley LF; Aldemerdash A; Fanikos J; Dell'Orfano H
Cardiovasc Hematol Disord Drug Targets; 2017; 17(2):132-135. PubMed ID: 28891451
[TBL] [Abstract][Full Text] [Related]
8. Systemic thrombolysis for acute pulmonary embolism.
Bartel B
Hosp Pract (1995); 2015; 43(1):22-7. PubMed ID: 25559613
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic Therapy by Tissue Plasminogen Activator for Pulmonary Embolism.
Islam MS
Adv Exp Med Biol; 2017; 906():67-74. PubMed ID: 27628004
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
11. Transforming and simplifying the treatment of pulmonary embolism: "safe dose" thrombolysis plus new oral anticoagulants.
Sharifi M; Vajo Z; Freeman W; Bay C; Sharifi M; Schwartz F
Lung; 2015 Jun; 193(3):369-74. PubMed ID: 25749665
[TBL] [Abstract][Full Text] [Related]
12. [Low doses of rtPA administered as a bolus in treatment of clinically acute massive pulmonary embolism].
Tomkowski W; Borowiec B; Hajduk B; Kober J; Burakowski J; Oniszh K; Pawlicka L; Filipecki S
Pneumonol Alergol Pol; 1996; 64 Suppl 2():161-5. PubMed ID: 9181884
[TBL] [Abstract][Full Text] [Related]
13. Safety of Therapeutic Anticoagulation with Low-Molecular-Weight Heparin or Unfractionated Heparin Infusion during Catheter-Directed Thrombolysis for Acute Pulmonary Embolism.
Graif A; Kimbiris G; Grilli CJ; Agriantonis DJ; Putnam SG; Leung DA
J Vasc Interv Radiol; 2020 Apr; 31(4):537-543. PubMed ID: 31959518
[TBL] [Abstract][Full Text] [Related]
14. Thrombolytic therapy in pulmonary embolism.
Goldhaber SZ; Bounameaux H
Semin Vasc Med; 2001 Nov; 1(2):213-20. PubMed ID: 15199505
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis of venous and arterial thrombosis by catheter-directed low-dose infusion of tissue plasminogen activator in children.
Cannizzaro V; Berger F; Kretschmar O; Saurenmann R; Knirsch W; Albisetti M
J Pediatr Hematol Oncol; 2005 Dec; 27(12):688-91. PubMed ID: 16344680
[TBL] [Abstract][Full Text] [Related]
16. Low-dose systemic thrombolytic therapy for treatment of submassive pulmonary embolism: Clinical efficacy but attendant hemorrhagic risks.
Rothschild DP; Goldstein JA; Bowers TR
Catheter Cardiovasc Interv; 2019 Feb; 93(3):506-510. PubMed ID: 30549393
[TBL] [Abstract][Full Text] [Related]
17. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study.
Ouriel K; Katzen B; Mewissen M; Flick P; Clair DG; Benenati J; McNamara TO; Gibbens D
J Vasc Interv Radiol; 2000; 11(7):849-54. PubMed ID: 10928520
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery.
Zencirkiran Agus H; Uygur B; Guler A; Demirci G; Kalkan AK; Yildiz M
Blood Coagul Fibrinolysis; 2018 Sep; 29(6):559-561. PubMed ID: 29985194
[TBL] [Abstract][Full Text] [Related]
19. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
[TBL] [Abstract][Full Text] [Related]
20. Current Controversies in Thrombolytic Use in Acute Pulmonary Embolism.
Long B; Koyfman A
J Emerg Med; 2016 Jul; 51(1):37-44. PubMed ID: 27071316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
